This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use ...
COVID-19/traitement médicamenteux,
Hormones corticosurrénaliennes/usage thérapeutique,
Antiviraux/usage thérapeutique,
COVID-19/complications,
Embolie pulmonaire/complications,
Poumon/anatomopathologie,
Anticoagulants/usage thérapeutique,
Dabigatran/usage thérapeutique,
Héparine/usage thérapeutique,
4-Hydroxycoumarines/usage thérapeutique,
Acide acétylsalicylique/usage thérapeutique
This guideline covers vitamin D use in the context of COVID‑19. It is for adults, young people and children in hospitals and community settings. Vitamin D is important for bone and muscle health. It may also have a role in the body's immune response to respiratory viruses. On 14 July 2022, we removed t...
This guideline was developed before the COVID-19 pandemic. It covers diagnosing and managing pneumonia in adults who do not have COVID-19. It aims to improve accurate assessment and diagnosis of pneumonia to help guide antibiotic prescribing and ensure that people receive the right treatment.
July 2022:...
Background & aims: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder associated with significant disease burden. This American Gastroenterological Association Guideline is intended to support practitioners in decisions about the use of medications for the pharmacological man...
Irritable bowel syndrome (IBS) is a common disorder of gut–brain interaction associated with significant disease burden. This American Gastroenterological Association guideline is intended to support practitioners in decisions about the use of medications for the pharmacological management of IBS-C and...
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for people with multiple sclerosis by promoting prompt and effective symptom management and relapse treatment, and comprehensive reviews.
NICE has also produced technology ...
Sclérose en plaques/thérapie,
Sclérose en plaques/diagnostic,
Ataxie/thérapie,
Inbiteurs sélectifs de la recapture de la sérotonine/usage thérapeutique,
Fatigue/thérapie,
Sclérose en plaques/rééducation et réadaptation,
Fatigue/traitement médicamenteux,
Mobilité réduite,
Spasticité musculaire/traitement médicamenteux,
Dystonie/traitement médicamenteux,
Tremblement/traitement médicamenteux
Las leishmaniasis son enfermedades infecciosas desatendidas de gran importancia en la Región de las Américas debido a su morbilidad, mortalidad y amplia distribución geográfica. De las tres formas clínicas principales, la cutánea es la más común y la visceral es la forma más grave, ya que puede ...
Leishmaniose/traitement médicamenteux,
Leishmaniose/prévention et contrôle,
Antiprotozoaires/usage thérapeutique,
Amériques,
Leishmaniose viscérale/traitement médicamenteux,
Leishmaniose cutanéomuqueuse/traitement médicamenteux,
Leishmaniose cutanée/traitement médicamenteux,
Maladies négligées/traitement médicamenteux,
Prévention des Maladies,
Hyperthermie provoquée/méthodes,
Paromomycine/usage thérapeutique
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released in 2018 ...
This guideline covers interventions to prevent sexually transmitted infections (STIs) in people aged 16 and over. It aims to reduce the transmission of all STIs, including HIV, and includes ways to help increase the uptake of STI testing and vaccines for human papillomavirus (HPV) and hepatitis A and B....
This guideline covers the care of women at increased risk of, or with symptoms and signs of, preterm labour (before 37 weeks), and women having a planned preterm birth. It aims to reduce the risks of preterm birth for the baby and describes treatments to prevent or delay early labour and birth.
In this ...
